arrow
返回
J

Johnson & Johnson Usa

学者数3.2K
论文数2.3K
被引数0
关联论文 (2251)
发表时间
Validity and Psychometric Properties of 3 and 4 Visual Analog Scale in Participants With Psoriatic Arthritis Treated With Guselkumab3和4视觉模拟量表在应用 guselkumab治疗的银屑病关节炎患者中的有效性和心理测量特性
err2026-05-01
err0
PREAI
errTillett, William; Coates, Laura C.; Vis, Marijn; Zimmermann, Miriam; Lozenski, Karissa; Rampakakis, Emmanouil; Soriano, Enrique R.; Merola, Joseph F.; Sharaf, Mohamed; Nash, Peter; Helliwell, Philip S.
err分享
err收藏
Homologous Recombination Repair Mutations, Next-generation Sequencing Testing, and Treatment Progression by Race Among Patients With Metastatic Castration-sensitive Prostate Cancer同源重组修复突变、下一代测序检测及不同种族转移性去势敏感前列腺癌患者的治疗进展
err2026-05-01
err0
PREAI
errBilen, Mehmet A.; Shore, Neal; Burbage, Sabree; Rossi, Carmine; Diaz, Lilian; Khilfeh, Ibrahim; Wang, Yuxi; Wong, Gordon; Pilon, Dominic; Brown, Gordon; Lowentritt, Benjamin; Lin, Daniel W.
err分享
err收藏
Target product profiles for treatments to delay or prevent symptomatic Alzheimer's disease用于延缓或预防症状性阿尔茨海默病治疗的靶产品特征
err2026-04-01
err0
PREAI
errCummings, Jeffrey L.; Agadjanyan, Michael G.; Barry, Maureen; Corey, Lawrence; Doody, Rachelle; Hendrix, Suzanne; Mattke, Soeren; Mattsson-Carlgren, Niklas; Mcdade, Eric; Menetski, Joseph P.; Mohs, Richard C.; Partrick, Katherine A.; Petrovsky, Nikolai; Selkoe, Dennis J.; Silva, Diego; Sperling, Reisa A.; Tiede, Benjamin; Vradenburg, George
err分享
err收藏
TECLISTAMY (EMN40): A PHASE 2 TRIAL OF TECLISTAMAB IN PATIENTS WITH PREVIOUSLY TREATED LIGHT-CHAIN AL AMYLOIDOSISTECLISTAMY (EMN40):一项关于TECLISTAMAB治疗既往接受过治疗的轻链AL淀粉样变性的II期临床试验
err2026-04-01
err0
PREAI
errRoussel, M.; Kastritis, E.; Schonland, S. O.; Kortum, K. M.; Arnulf, B.; Jaccard, A.; Vara, S.; Doyle, M.; Schecter, J. M.; Carpinteiro, A.; Kwok, F.; Palladini, G.; Minnema, M. C.; Boccadoro, M.; Sonneveld, P.
err分享
err收藏
EFFECTIVENESS OF BRIDGING THERAPY CORRESPONDS TO IMPROVED OUTCOMES AFTER CILTACABTAGENE AUTOLEUCEL: PHASE 3 CARTITUDE-4 STUDY OF PATIENTS WITH RELAPSED, LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA桥接疗法的效果与CILTA-CAR-T治疗后结局改善相关:第3期CARTITUDE-4研究,针对复发、来那度胺难治性多发性骨髓瘤患者
err2026-04-01
err0
PREAI
errZamagni, E.; Dhakal, B.; Iida, S.; Sidiqi, M. H.; Yoon, S. S.; Callander, N.; Touzeau, C.; Li, Q.; Balogh, A.; Slaughter, A.; Benachour, N.; Lonardi, C.; Ghosh, A.; Vogel, M.; Lendvai, N.; Lengil, T.; Koneru, M.; Patel, N.; Costa Filho, O.; Mahajan, V.; Martinez-Lopez, J.; Yong, K.; Weisel, K.; Leleu, X.
err分享
err收藏
CILTACABTAGENE AUTOLEUCEL OUT-OF-SPECIFICATION MANUFACTURING OUTCOMES IMPROVE WITH EARLIER LINES OF THERAPYCILTACABTAGENE AUTOLEUCEL 不符合规格的生产结果随着更早的治疗线而改善
err2026-04-01
err0
PREAI
errBowden, R.; Van Eeckhoutte, H.; Chow, G.; Choudhary, G.; Kallenbach, L.; Alegria, V.; Perciavalle, M.; Salmon, J.; Kang, J.; Mondon, M.; Vanak, J.; Ciccone, D.; Millili, P.; Onorata, M.; Plaks, V.; Merz, M.
err分享
err收藏
SAFETY AND EFFICACY OF TALQUETAMAB plus TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM PHASE 1B OF REDIRECTT-1: RESULTS WITH AN EXTENDED MEDIAN FOLLOW-UP OF 3 YEARSTALQUETAMAB联合TECLISTAMAB在复发/难治性多发性骨髓瘤患者中的安全性与有效性:REDIRECTT-1试验1B期研究3年扩展中位随访结果
err2026-04-01
err0
PREAI
errOcio, E. M.; Mateos, M-V.; Magen, H.; Gatt, M.; Sebag, M.; Kim, K.; Min, C-K.; Yoon, S-S.; Chu, M. P.; Rodriguez-Otero, P.; Avivi, I.; Carde, N. A. Quijano; Krevvata, M.; Henninger, T.; Thakkar, P.; Festa, M.; Huang, L.; Zhou, J. X.; Takamoto, M.; Pei, L.; Lu, J.; Maffucci, C.; Scott, E.; Oriol, A.; Morillo, D.; Cohen, Y. C.
err分享
err收藏